LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer

LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer

BackgroundTriple-negative breast cancer (TNBC) is a significant cause of patient morbidity. The exactly pathobiological features of this condition has yet to be completely elucidated.MethodsBreast cancer data obtained from The Cancer Genome Atlas (TCGA) database were evaluated for lncRNA SNHG6 expre...

Full description

Bibliographic Details
Main Authors: Yufei Lv, Xiaohong Lv, Huike Yang, Xiuying Qi, Xiangchen Wang, Chao Li, Xiaochen Shang, Hongmin Guo, Jianguo Zhang, Yafang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
lncRNA SNHG6
miR-125b-5p
BMPR1B
Triple-negative breast cancer (TNBC)
competing endogenous RNAs (ceRNA)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.678474/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.678474/full

Similar Items